These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
355 related articles for article (PubMed ID: 24134931)
21. GATA3 expression in paragangliomas: a pitfall potentially leading to misdiagnosis of urothelial carcinoma. So JS; Epstein JI Mod Pathol; 2013 Oct; 26(10):1365-70. PubMed ID: 23599157 [TBL] [Abstract][Full Text] [Related]
25. Cytokeratin 20 expression is linked to stage progression and to poor prognosis in advanced (pT4) urothelial carcinoma of the bladder. Bruch PG; Plage H; Hofbauer S; Kornienko K; Weinberger S; Roßner F; Schallenberg S; Kluth M; Lennartz M; Blessin NC; Marx AH; Samtleben H; Fisch M; Rink M; Slojewski M; Kaczmarek K; Ecke T; Hallmann S; Koch S; Adamini N; Minner S; Simon R; Sauter G; Zecha H; Klatte T; Schlomm T; Horst D; Elezkurtaj S Exp Mol Pathol; 2023 Jun; 131():104860. PubMed ID: 36997051 [TBL] [Abstract][Full Text] [Related]
26. Strong androgen receptor expression is not useful in distinguishing GATA3 + metastases. Lionti S; La Rocca L; Nunnari CM; Barresi V Pathol Res Pract; 2018 Dec; 214(12):2110-2114. PubMed ID: 30293951 [TBL] [Abstract][Full Text] [Related]
27. Alterations of mTOR and PTEN protein expression in schistosomal squamous cell carcinoma and urothelial carcinoma. Makboul R; Refaiy A; Abdelkawi IF; Hameed DA; Elderwy AA; Shalaby MM; Merseburger AS; Hussein MR Pathol Res Pract; 2016 May; 212(5):385-92. PubMed ID: 26916953 [TBL] [Abstract][Full Text] [Related]
28. Value of GATA3 immunostaining in tumor diagnosis: a review. Ordóñez NG Adv Anat Pathol; 2013 Sep; 20(5):352-60. PubMed ID: 23939152 [TBL] [Abstract][Full Text] [Related]
29. Use of PAX8 and GATA3 in diagnosing sarcomatoid renal cell carcinoma and sarcomatoid urothelial carcinoma. Chang A; Brimo F; Montgomery EA; Epstein JI Hum Pathol; 2013 Aug; 44(8):1563-8. PubMed ID: 23453625 [TBL] [Abstract][Full Text] [Related]
30. Semiquantitative GATA-3 immunoreactivity in breast, bladder, gynecologic tract, and other cytokeratin 7-positive carcinomas. Clark BZ; Beriwal S; Dabbs DJ; Bhargava R Am J Clin Pathol; 2014 Jul; 142(1):64-71. PubMed ID: 24926087 [TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical staining for p63 is useful in the diagnosis of anal squamous cell carcinomas. Owens SR; Greenson JK Am J Surg Pathol; 2007 Feb; 31(2):285-90. PubMed ID: 17255774 [TBL] [Abstract][Full Text] [Related]
32. Plasmacytoid urothelial carcinoma of the urinary bladder: clinicopathologic, immunohistochemical, ultrastructural, and molecular analysis of a case series. Raspollini MR; Sardi I; Giunti L; Di Lollo S; Baroni G; Stomaci N; Menghetti I; Franchi A Hum Pathol; 2011 Aug; 42(8):1149-58. PubMed ID: 21334719 [TBL] [Abstract][Full Text] [Related]
33. Carcinoma of the urethra. Zhang M; Adeniran AJ; Vikram R; Tamboli P; Pettaway C; Bondaruk J; Liu J; Baggerly K; Czerniak B Hum Pathol; 2018 Feb; 72():35-44. PubMed ID: 28827100 [TBL] [Abstract][Full Text] [Related]
34. Invasive urothelial carcinoma with chordoid features: a report of 12 distinct cases characterized by prominent myxoid stroma and cordlike epithelial architecture. Cox RM; Schneider AG; Sangoi AR; Clingan WJ; Gokden N; McKenney JK Am J Surg Pathol; 2009 Aug; 33(8):1213-9. PubMed ID: 19542871 [TBL] [Abstract][Full Text] [Related]
35. Optimal immunohistochemical markers for distinguishing lung adenocarcinomas from squamous cell carcinomas in small tumor samples. Terry J; Leung S; Laskin J; Leslie KO; Gown AM; Ionescu DN Am J Surg Pathol; 2010 Dec; 34(12):1805-11. PubMed ID: 21107086 [TBL] [Abstract][Full Text] [Related]
36. Noninvasive squamous lesions in the urinary bladder: a clinicopathologic analysis of 29 cases. Guo CC; Fine SW; Epstein JI Am J Surg Pathol; 2006 Jul; 30(7):883-91. PubMed ID: 16819332 [TBL] [Abstract][Full Text] [Related]
37. GATA3 expression in small cell carcinoma of bladder and prostate and its potential role in determining primary tumor origin. Bezerra SM; Lotan TL; Faraj SF; Karram S; Sharma R; Schoenberg M; Bivalacqua TJ; Netto GJ Hum Pathol; 2014 Aug; 45(8):1682-7. PubMed ID: 24925221 [TBL] [Abstract][Full Text] [Related]
38. Utility of uroplakin II expression as a marker of urothelial carcinoma. Tian W; Guner G; Miyamoto H; Cimino-Mathews A; Gonzalez-Roibon N; Argani P; Li X; Sharma R; Subhawong AP; Rezaei K; Bivalacqua TJ; Epstein JI; Bishop JA; Netto GJ Hum Pathol; 2015 Jan; 46(1):58-64. PubMed ID: 25449628 [TBL] [Abstract][Full Text] [Related]
39. Clinicopathological features of carcinoma of the distal penile urethra. Corbishley CM; Rajab RM; Watkin NA Semin Diagn Pathol; 2015 May; 32(3):238-44. PubMed ID: 25656527 [TBL] [Abstract][Full Text] [Related]
40. Expression of caveolin-1 and caveolin-2 in urothelial carcinoma of the urinary bladder correlates with tumor grade and squamous differentiation. Fong A; Garcia E; Gwynn L; Lisanti MP; Fazzari MJ; Li M Am J Clin Pathol; 2003 Jul; 120(1):93-100. PubMed ID: 12866378 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]